Rectal cancer: presentation with metastatic and locally advanced disease. American College of Radiology. ACR Appropriateness Criteria.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 11037562)

Published in Radiology on June 01, 2000

Authors

L Saltz1, D Raben, B D Minsky, J L Bader, L R Coia, N A Janjan, M J John, G S Merrick, T A Rich, S A Rosenthal, J E Tepper, D Ota, S Leibel

Author Affiliations

1: Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Articles by these authors

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med (1998) 7.60

Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst (2001) 5.68

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys (2000) 4.99

Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol (1976) 4.52

Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. Med Phys (1994) 4.13

Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. Int J Radiat Oncol Biol Phys (1995) 3.86

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys (2001) 3.70

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med (1994) 3.29

Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg (1992) 2.98

Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys (1988) 2.95

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol (1997) 2.75

Late presentation of HIV infection: a consensus definition. HIV Med (2011) 2.67

3-D beams need 3-D names. Int J Radiat Oncol Biol Phys (1990) 2.59

Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare. J Clin Oncol (2001) 2.43

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. J Clin Oncol (2000) 2.39

Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys (1999) 2.29

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol (2001) 2.24

Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys (1995) 2.22

Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer. J Clin Oncol (1999) 2.19

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology (1995) 2.17

Linkage analysis of neurofibromatosis (von Recklinghausen disease). J Med Genet (1983) 2.13

Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys (1990) 2.11

Extraskeletal Ewing's sarcoma: results of combined modality treatment. J Clin Oncol (1983) 1.99

Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys (1991) 1.97

Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol (1999) 1.95

The role of Langerhans cells in allergic contact hypersensitivity. A review of findings in man and guinea pigs. J Invest Dermatol (1976) 1.93

Comparison of 1 vs 2 or more intracavitary brachytherapy applications in the management of carcinoma of the cervix, with irradiation alone. Int J Radiat Oncol Biol Phys (1991) 1.93

Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. J Clin Oncol (2000) 1.92

A pilot study of preoperative chemoradiotherapy for resectable gastric cancer. Ann Surg Oncol (2001) 1.85

Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery (1999) 1.79

Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology (2001) 1.76

Capromab Pendetide imaging of prostate cancer. Cancer Biother Radiopharm (2000) 1.75

Isotope selection for patients undergoing prostate brachytherapy. Int J Radiat Oncol Biol Phys (1999) 1.71

Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study. Br J Cancer (2006) 1.71

Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis (2009) 1.70

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys (2002) 1.69

Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol (1999) 1.68

Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. Int J Radiat Oncol Biol Phys (2001) 1.67

Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg (1995) 1.66

Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys (1991) 1.62

Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev (1989) 1.60

Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res (1998) 1.59

Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. Cancer J (2001) 1.58

Inhibition of growth of 3T3 cells by extract of surface membranes. Proc Natl Acad Sci U S A (1978) 1.56

Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg (1997) 1.53

Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg (1996) 1.52

Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum. Ann Surg Oncol (1999) 1.50

Re-resection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field. Cancer J Sci Am (1999) 1.48

Adenocarcinoma of the esophagus and esophago-gastric junction: the effects of single and combined modalities on the survival and patterns of failure following treatment. Int J Radiat Oncol Biol Phys (1990) 1.48

The case for indicator condition-guided HIV screening. HIV Med (2013) 1.48

Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg (1986) 1.47

Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. Clin Cancer Res (2001) 1.46

Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer (1992) 1.45

Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol (1996) 1.44

Extramammary Paget's disease of the perineal skin: role of radiotherapy. Int J Radiat Oncol Biol Phys (1992) 1.44

2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol (2000) 1.43

Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol (2001) 1.42

Clinically relevant optimization of 3-D conformal treatments. Med Phys (1992) 1.42

Radiotherapy for anal cancer: experience from 1979-1987. Int J Radiat Oncol Biol Phys (1989) 1.42

Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment. Int J Radiat Oncol Biol Phys (1995) 1.42

Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys (1997) 1.42

Mandibular reconstruction using a titanium plate: the impact of radiation therapy on plate preservation. Int J Radiat Oncol Biol Phys (1995) 1.41

Neurofibromatosis and childhood leukemia. J Pediatr (1978) 1.41

Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg (1993) 1.41

Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum (1997) 1.41

Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival. Surgery (1997) 1.40

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. J Clin Oncol (1999) 1.39

Adjuvant radiotherapy for rectal cancer: more on pre- or postoperative therapy. Int J Radiat Oncol Biol Phys (1995) 1.39

Failure patterns following curative resection of colonic carcinoma. Ann Surg (1984) 1.39

Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol (1999) 1.39

Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation. Int J Radiat Oncol Biol Phys (1995) 1.39

Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience. Ann Oncol (2007) 1.38

Radiation therapy quality control in a clinical trial of adjuvant postoperative treatment for rectal cancer. Int J Radiat Oncol Biol Phys (1995) 1.35

Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg (1996) 1.35

Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum (2000) 1.32

Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys (2001) 1.30

Dermal and intravascular Langerhans cells at sites of passively induced allergic contact sensitivity. Cell Immunol (1975) 1.30

NCCN Practice Guidelines for Cancer Pain. Oncology (Williston Park) (2000) 1.30

Clinical and pathologic review of 48 cases of chordoma. Cancer (1985) 1.30

Radiation therapy of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys (1984) 1.30

The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys (1991) 1.30

Treatment of the patient with stage M0 soft tissue sarcoma. J Clin Oncol (1988) 1.29

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol (1998) 1.29

Role of radiotherapy in sarcoma of the breast--a retrospective review of the M.D. Anderson experience. Radiother Oncol (1999) 1.29

Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience. Surgery (1994) 1.28

Occult carcinoma of the breast masquerading as primary adenocarcinoma of the small intestine. A case report. J Clin Gastroenterol (1988) 1.28

Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma. J Clin Oncol (1991) 1.26

Potentially curative surgery of colon cancer: patterns of failure and survival. J Clin Oncol (1988) 1.25

Proton radiation as boost therapy for localized prostatic carcinoma. JAMA (1979) 1.25

Efficacy of "dermatophyte test medium". Comparison of two commercial preparations with laboratory-prepared Sabouraud-antibiotic medium. Arch Dermatol (1971) 1.24

Bilateral retinoblastoma with ectopic intracranial retinoblastoma: trilateral retinoblastoma. Cancer Genet Cytogenet (1982) 1.24

Primary cutaneous infection by Aspergillus ustus in a 62-year-old liver transplant recipient. J Am Acad Dermatol (1994) 1.23

Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys (1999) 1.23

Human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 2 (HSV-2) can coinfect and simultaneously replicate in the same human CD4+ cell: effect of coinfection on infectious HSV-2 and HIV-1 replication. AIDS Res Hum Retroviruses (1990) 1.23

Tumor uptake and elimination of 2',2'-difluoro-2'-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: correlation with in vivo tumor response. Clin Cancer Res (2001) 1.22